title: Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.
abstract: Current and emerging formulation strategies for skin permeation are poised to open the transdermal drug delivery to a broader range of small molecule compounds that do not fit the traditional requirements for successful transdermal drug delivery, allowing the development of new patch technologies to deliver antiretroviral drugs that were previously incapable of being delivered through transdermal means. Transdermal drug delivery offers several distinct advantages over traditional dosage forms. Current antiretroviral drugs used for the treatment of HIV infection include a variety of highly active small molecule compounds with significantly limited skin permeability, and thus new and novel means of enhancing transport through the skin are needed. Current and emerging formulation strategies are poised to open the transdermal drug delivery to a broader range of compounds that do not fit the traditional requirements for successful transdermal drug delivery, allowing the development of new patch technologies to deliver antiretroviral drugs that were previously incapable of being delivered through transdermal means. Thus, with continuing research into skin permeability and patch formulation strategies, there is a large potential for antiretroviral transdermal drug delivery.
authors.affiliation: ImQuest BioSciences Inc., 7340 Executive Way, Suite R, Frederick, MD 21704, USA.
authors.forename: Anthony S
authors.initials: AS
authors.lastname: Ham
authors.forename: Robert W
authors.initials: RW
authors.lastname: Buckheit
mesh_terms: D000279:Administration, Cutaneous; D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical / Q000379:methods; D016503:Drug Delivery Systems; D015195:Drug Design; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010539:Permeability; D012869:Skin Absorption; D057968:Transdermal Patch
chemical_list: D019380:Anti-HIV Agents